SK14102000A3 - Paroxetín alebo jeho farmaceuticky prijateľný derivát, farmaceutický prostriedok s jeho obsahom a jeho použitie - Google Patents
Paroxetín alebo jeho farmaceuticky prijateľný derivát, farmaceutický prostriedok s jeho obsahom a jeho použitie Download PDFInfo
- Publication number
- SK14102000A3 SK14102000A3 SK1410-2000A SK14102000A SK14102000A3 SK 14102000 A3 SK14102000 A3 SK 14102000A3 SK 14102000 A SK14102000 A SK 14102000A SK 14102000 A3 SK14102000 A3 SK 14102000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- paroxetine
- solid carrier
- solvent
- pharmaceutically acceptable
- acceptable derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9806312.6A GB9806312D0 (en) | 1998-03-24 | 1998-03-24 | Novel formulations |
| PCT/GB1999/000922 WO1999048499A1 (en) | 1998-03-24 | 1999-03-24 | Paroxetine compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK14102000A3 true SK14102000A3 (sk) | 2001-03-12 |
Family
ID=10829181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1410-2000A SK14102000A3 (sk) | 1998-03-24 | 1999-03-24 | Paroxetín alebo jeho farmaceuticky prijateľný derivát, farmaceutický prostriedok s jeho obsahom a jeho použitie |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1063993A1 (ja) |
| JP (1) | JP2002507569A (ja) |
| CN (1) | CN1125639C (ja) |
| AP (1) | AP2000001914A0 (ja) |
| AU (1) | AU754765B2 (ja) |
| BG (1) | BG104865A (ja) |
| BR (1) | BR9908991A (ja) |
| CA (1) | CA2324612A1 (ja) |
| EA (1) | EA003393B1 (ja) |
| GB (1) | GB9806312D0 (ja) |
| HU (1) | HUP0101326A3 (ja) |
| ID (1) | ID26485A (ja) |
| IL (1) | IL138478A0 (ja) |
| NO (1) | NO313404B1 (ja) |
| NZ (1) | NZ506893A (ja) |
| PL (1) | PL343095A1 (ja) |
| SK (1) | SK14102000A3 (ja) |
| TR (1) | TR200002750T2 (ja) |
| WO (1) | WO1999048499A1 (ja) |
| ZA (1) | ZA200005697B (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9914600D0 (en) * | 1999-06-22 | 1999-08-25 | Smithkline Beecham Plc | Novel,process |
| DK200100341A (da) * | 2001-03-02 | 2002-09-03 | Gea Farmaceutisk Fabrik As | Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat |
| EP1643975A2 (en) * | 2003-07-02 | 2006-04-12 | Abbott Laboratories | Process for preparing formulations of lipid-regulating drugs |
| US8062664B2 (en) | 2003-11-12 | 2011-11-22 | Abbott Laboratories | Process for preparing formulations of lipid-regulating drugs |
| HU1000278D0 (en) * | 2010-05-28 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | Novel pharmaceutical use uf silicic acid |
| CN103961333B (zh) * | 2014-05-07 | 2020-02-21 | 浙江华海药业股份有限公司 | 甲磺酸帕罗西汀胶囊及其制备方法 |
| CN104027306A (zh) * | 2014-06-25 | 2014-09-10 | 万特制药(海南)有限公司 | 帕罗西汀口服混悬液及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| AR001982A1 (es) * | 1995-02-06 | 1998-01-07 | Smithkline Beecham Plc | Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion |
| CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
-
1998
- 1998-03-24 GB GBGB9806312.6A patent/GB9806312D0/en not_active Ceased
-
1999
- 1999-03-24 EP EP99911940A patent/EP1063993A1/en not_active Withdrawn
- 1999-03-24 TR TR2000/02750T patent/TR200002750T2/xx unknown
- 1999-03-24 EA EA200000977A patent/EA003393B1/ru not_active IP Right Cessation
- 1999-03-24 NZ NZ506893A patent/NZ506893A/xx unknown
- 1999-03-24 AU AU30451/99A patent/AU754765B2/en not_active Withdrawn - After Issue
- 1999-03-24 WO PCT/GB1999/000922 patent/WO1999048499A1/en not_active Application Discontinuation
- 1999-03-24 IL IL13847899A patent/IL138478A0/xx unknown
- 1999-03-24 JP JP2000537547A patent/JP2002507569A/ja active Pending
- 1999-03-24 PL PL99343095A patent/PL343095A1/xx unknown
- 1999-03-24 SK SK1410-2000A patent/SK14102000A3/sk unknown
- 1999-03-24 CA CA002324612A patent/CA2324612A1/en not_active Abandoned
- 1999-03-24 HU HU0101326A patent/HUP0101326A3/hu unknown
- 1999-03-24 CN CN99804347A patent/CN1125639C/zh not_active Expired - Fee Related
- 1999-03-24 AP APAP/P/2000/001914A patent/AP2000001914A0/en unknown
- 1999-03-24 ID IDW20001883A patent/ID26485A/id unknown
- 1999-03-24 BR BR9908991-2A patent/BR9908991A/pt not_active IP Right Cessation
-
2000
- 2000-09-22 NO NO20004740A patent/NO313404B1/no unknown
- 2000-10-16 ZA ZA200005697A patent/ZA200005697B/xx unknown
- 2000-10-16 BG BG104865A patent/BG104865A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU754765B2 (en) | 2002-11-21 |
| EP1063993A1 (en) | 2001-01-03 |
| NO313404B1 (no) | 2002-09-30 |
| IL138478A0 (en) | 2001-10-31 |
| CA2324612A1 (en) | 1999-09-30 |
| AU3045199A (en) | 1999-10-18 |
| BG104865A (en) | 2001-05-31 |
| TR200002750T2 (tr) | 2000-12-21 |
| ID26485A (id) | 2001-01-11 |
| CN1125639C (zh) | 2003-10-29 |
| WO1999048499A1 (en) | 1999-09-30 |
| NO20004740L (no) | 2000-10-03 |
| HUP0101326A2 (hu) | 2002-05-29 |
| JP2002507569A (ja) | 2002-03-12 |
| PL343095A1 (en) | 2001-07-30 |
| BR9908991A (pt) | 2000-12-12 |
| EA200000977A1 (ru) | 2001-02-26 |
| NZ506893A (en) | 2003-06-30 |
| AP2000001914A0 (en) | 2000-09-30 |
| CN1294512A (zh) | 2001-05-09 |
| HUP0101326A3 (en) | 2002-06-28 |
| EA003393B1 (ru) | 2003-04-24 |
| ZA200005697B (en) | 2001-10-02 |
| GB9806312D0 (en) | 1998-05-20 |
| NO20004740D0 (no) | 2000-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0183027B1 (ko) | 류코트리엔의 작용에 대한 길항작용이 요구되는 질환의 치료용 약학 조성물 및 이의 제조 방법 | |
| RU2378272C2 (ru) | Небиволол и его фармацевтически приемлемые соли, способ их получения и фармацевтические композиции небиволола | |
| JPH0768140B2 (ja) | 安定化された医薬物質、その製法および安定な医薬製剤 | |
| CA2150131C (en) | Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity | |
| WO2011012322A2 (en) | Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms | |
| KR100762022B1 (ko) | 레보시멘단의 경구용 조성물 | |
| KR20070085090A (ko) | ５－ｈｔ１ａ 수용체 길항제의 약제학적 투여 형태 및조성물 | |
| SK14102000A3 (sk) | Paroxetín alebo jeho farmaceuticky prijateľný derivát, farmaceutický prostriedok s jeho obsahom a jeho použitie | |
| US6699882B2 (en) | Paroxetine compositions | |
| RU2199318C2 (ru) | Стабилизированные в отношении рацемизации фармацевтические лекарственные формы силанзетрона | |
| NZ549100A (en) | Crystalline composition containing escitalopram oxalate | |
| AU2003200534B2 (en) | Paroxetine compositions | |
| MXPA00009340A (en) | Paroxetine compositions | |
| KR20010042145A (ko) | 파록세틴 조성물 | |
| KR100896563B1 (ko) | 축합 인돌 화합물을 포함하는 제약 조성물 | |
| CZ20003489A3 (cs) | Paroxetinové kompozice | |
| EP2943454B1 (en) | Tapentadol maleate and crystalline forms thereof | |
| EP4081193A1 (en) | Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules | |
| AU2009219892B2 (en) | Novel crystalline forms | |
| GB2397301A (en) | Substituted 1,3,5-triazine derivatives | |
| SK15912000A3 (sk) | Askorbát paroxetínu, spôsob jeho výroby a jeho použitie | |
| CN103860473A (zh) | 一种度洛西汀药物组合物 | |
| SK17142000A3 (sk) | Hydrochlorid paroxetínu vo forme inej než hemihydrát formulovaný do tabliet, spôsob výroby tabliet hydrochloridu paroxetínu a súprava zahrnujúca takéto tablety | |
| SK15902000A3 (sk) | 10-gáforsulfonát paroxetínu, spôsob jeho výroby a jeho použitie | |
| WO2000078288A2 (en) | Novel process for paroxetine compositions |